Navigation Links
Boehringer Ingelheim's interferon-free hepatitis C treatment portfolio strengthened by promising interim Phase 2a data
Date:11/2/2013

esidio's NS5B inhibitor, PPI-383, is a novel pan-genotypic non-nucleoside inhibitor with potential to inhibit all of the major HCV genotypes.  This compound is currently in Phase 1 studies in healthy subjects.  For more information, please visit www.presidiopharma.com.

Contact:
Boehringer Ingelheim Pharmaceuticals, Inc.
Name: Susanne Granold
Public Relations
Phone: 203-791-5851
Email: usnews@boehringer-ingelheim.com


'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 3, 2015 Today, the world,s ... As markets become ever more transparent, the importance of ... recognised long ago. Its maxim of "innovation brings progress ... and digitisation. The company has long been ... of the art" technology and modern approach, while also ...
(Date:6/2/2015)... 2, 2015  Endo International plc (NASDAQ: ENDP ... that it has commenced an underwritten public offering of ... shares in the offering are to be sold by ... to the underwriters of the Offering an option, exercisable ... of the final prospectus supplement, to purchase an additional ...
(Date:6/2/2015)...  MGC Diagnostics Corporation (NASDAQ: MGCD ), ... results for the second quarter ended April 30, ... equipment, supplies and accessories revenues, compared to the ... During the quarter, competitive account conversions totaled 12 ... accounts, or $850,000 in revenue for the same ...
Breaking Medicine Technology:Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 2Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 3Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14
... 2007 - Lux Biosciences,Inc., a privately held biotechnology ... today that the company's,next-generation calcineurin inhibitor, LX211, is ... Research in Vision and,Ophthalmology (ARVO) annual meeting, being ... an oral presentation being given on May 5 ...
... at 59th American Academy of Neurology Annual Meeting, ... /PRNewswire/ --,PTC Therapeutics, Inc. (PTC), a biopharmaceutical company ... targeting,post-transcriptional control processes, today announced positive,interim data from ... patients,with Duchenne muscular dystrophy (DMD) due to a ...
Cached Medicine Technology:Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Additional Positive Interim Phase 2,Results of PTC124 in Duchenne Muscular Dystrophy 5
(Date:6/3/2015)... Veatch Consulting Services is excited to announce their achievement ... in April 2006, they have made it a priority ... and every year they have worked diligently in surpassing ... that they are off to a great start already ... year is the Customer Review site veatchconsultingreviews.weebly.com. At this ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 evigilo, ... multi-channel solutions, has showcased its new branding by launching ... , "The new brand identity: the logo depicting ... red, to green, the tagline – To Know. To ... new path evigilo is charting. A global, borderless approach ...
(Date:6/2/2015)... 02, 2015 The organic cotton market ... Report, an annual study conducted by Textile Exchange, an ... industry. The report, released today, encompasses extensive data about ... worldwide level and also takes the opportunity to celebrate ... , The last several years have been ...
(Date:6/2/2015)... Aidan Booth And Steve Clayton's ... yesterday, and has since received rave reviews from ... Tiffany Hendricks has weighed in with her opinion ... on her website HonestyFirstReviews.com. , "These days the ... looking to hone their business skills has gotten ...
(Date:6/2/2015)... June 02, 2015 April 8th, 2015, ... venue into Durkin Entertainment’s “RockNRolla Movie Awards” EcoLuxe Lounge, ... that gathered some of the world’s top providers of ... event was organized by Debbie Durkin, Los Angeles’ leading ... the EcoLuxe Lounge is a premier red carpet event ...
Breaking Medicine News(10 mins):Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2Health News:Choices Recovery South Bend Discusses Addiction With Rising Hollywood Star Ben Stillwell 2
... The number of U.S. hospitals has,decreased by 20% ... in 1975 to 5,747 in,2007. Meanwhile, staff shortages, ... errors, and rising administrative,and energy costs are squeezing ... costs, hospitals are increasingly turning,to the use of ...
... informed about health care services, ... ... (VA) has selected EDS to provide outbound calling services,and inbound callback support ... combat veterans more aware of,health care services and benefits available from the ...
... - Southeastern,Michigan Chapter took time out this week to ... of their time to help the Chapter,provide crucial support ... American Red Cross Volunteer Recognition events were held on,Monday ... night at Club,Venetian in Madison Heights., Red Cross ...
... - For low-back pain patients and their doctors, the ... is expanding its evidence-based, clinical practice guideline on diagnosis ... recommendations on surgery and other interventional treatments. The ... the APS Annual Scientific Meeting. , The second ...
... 9 /Xinhua-PRNewswire/ -- China Medicine,Corporation (OTC Bulletin ... leading developer and distributor of prescription and ... and dietary supplements, and medical devices and ... a conference call at,10:00 a.m. Eastern Time ...
... Offers In-Depth Understanding of Female Sexual Abuse of Minors, ... term "sexual,perpetrator" is tossed out there for consideration, a ... likely, this picture does not,involve a female perpetrator, but ... is a quickly growing phenomenon, and the National,Criminal Census ...
Cached Medicine News:Health News:Can Wireless Technologies Rescue U.S. Hospitals? 2Health News:EDS Chosen to Manage Combat Veteran Call Center for Department of Veterans Affairs 2Health News:American Red Cross of Southeastern Michigan Celebrates Outstanding Volunteers for Years of Service 2Health News:American Pain Society's low back guideline expanded to cover interventional procedures 2Health News:American Pain Society's low back guideline expanded to cover interventional procedures 3Health News:China Medicine Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:'Mommy Didn't Know': Female Sexual Offenders in the U.S. 2
Designed as an excellent form of primary suspension...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... orthosis is designed to comfortably restrict ... allowing unobstructed motion of the fingers ... fit the splint may be trimmed ... a heat gun. One cotton stockinet ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: